STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionApr 29, 2026, 08:02 AM

GHRS Prices $117.5M Underwritten Offering of 6.53M Shares at $18.00

AI Summary

GH Research PLC announced the pricing of an underwritten offering of 6,527,779 ordinary shares at $18.00 per share, aiming to raise approximately $117.5 million in gross proceeds. All shares are being offered by the company, with the offering expected to close on April 30, 2026. The offering saw participation from Lynx1 Capital Management, Deep Track Capital, and Foresite Capital, with Stifel, Cantor, and RBC Capital Markets acting as joint book-running managers.

Key Highlights

  • GHRS priced an underwritten offering of 6,527,779 ordinary shares.
  • Offering price set at $18.00 per share.
  • Total gross proceeds expected to be approximately $117.5 million.
  • All ordinary shares are being offered by GH Research PLC.
  • The offering is expected to close on April 30, 2026.
  • Lynx1 Capital Management, Deep Track Capital, and Foresite Capital participated.
  • Stifel, Cantor, and RBC Capital Markets are joint book-running managers.
GHRS
Biotechnology: Pharmaceutical Preparations
GH Research PLC

Price Impact